Skip to main content
. Author manuscript; available in PMC: 2020 Jun 1.
Published in final edited form as: J Sleep Res. 2018 Mar 5;28(3):e12666. doi: 10.1111/jsr.12666

TABLE 2.

Traditional PSG measures

Did not develop MCI/dementia (n = 85) Developed MCI/dementia (n = 85) p-value
Total sleep time (min) 348.7 (72.4) 354.5 (74.9) .61
WASO (min) 91.1 (59.1) 107.3 (66.0) .09
Sleep efficiency (%) 75.3 (12.0) 74.3 (13.3) .62
AHI (hypopneas with 3% desat) 14.2 (13.8) 14.3 (13.2) .74
AHI (hypopneas with 4% desat) 8.6 (10.6) 8.9 (10.6) .51
Percent sleep time SaO2 < 90% 3.5 (6.8) 3.2 (7.5) .45
Arousal index per hour of sleep 20.5 (11.1) 19.3 (10.4) .45
Time in stage 1 (%) 5.3 (3.3) 4.9 (2.7) .42
Time in stage 2 (%) 55.6 (9.8) 55.1 (13.5) .76
Time in stage ¾ (%) 19.9 (9.8) 22.0 (12.8) .23
Time in REM (%) 19.2 (6.7) 18.0 (7.7) .29
PLMS per hour of sleep 26.6 (28.3) 33.4 (35.7) .21
PLMS w/arousals per hour of sleep 3.7 (6.8) 4.1 (5.2) .13

M ± SD.

AHI, apnea-hypopnea index; MCI, mild cognitive impairment; PLMS, periodic limb movements of sleep; REM, rapid eye movement; WASO, wake after sleep onset.